For the Inventor, By the Inventor

Enter assignee name

Hamburg, Germany

Evotec Ag

Calculating rank

USPTO Granted Patents = 24

% Expired Patents = 37.5

CIPO Patents = 1

EPO Patents = 15

Trademarks = 2

Forward Citations = 22

Loading Chart...

Loading Chart...

52 inventors (with patents filed for the assignee):

John Kincaid (5 out of 19 patents)

Donogh John Roger O'Mahony (4 out of 11 patents)

Zhi-Liang Wei (4 out of 10 patents)

4. Carl J Kaub (4 out of 11 patents)

5. Zhan Wang (3 out of 21 patents)

6. David James Hallett (3 out of 3 patents)

7. Michael G Kelly (3 out of 72 patents)

8. Stefan Jäger (3 out of 3 patents)

9. Karsten Gall (3 out of 4 patents)

10. Adam James Davenport (2 out of 12 patents)

11. Matthew Duncton (2 out of 42 patents)

12. Kaupo Palo (2 out of 11 patents)

13. Peet Kask (2 out of 17 patents)

14. Yeyu Cao (2 out of 7 patents)

15. Sumithra Gowlugari (2 out of 6 patents)

24 patents: Sort by Forward Citations

1. 9759659 - Method for detecting the impacts of interfering effects on experimental data (2017-09-12),

2. 9133122 - Amide compounds, compositions and uses thereof (2015-09-15),

3. 8946439 - Amide compounds, compositions and uses thereof (2015-02-03),

4. 8912176 - Azetidines as histamine H3 receptor antagonists (2014-12-16),

5. 8859545 - Tetrahydronaphthyridine and tetrahydropyrido[4,3-D]pyrimidine compounds and compositions thereof useful for the treatment of inflammatory and respiratory diseases (2014-10-14),

6. 8691804 - Azetidines and cyclobutanes as histamine H3 receptor antagonists (2014-04-08),

7. 8653091 - Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof (2014-02-18),

8. 8623859 - Bradykinin B1 antagonists (2014-01-07),

9. 8580577 - Method for detecting an analyte in a sample (2013-11-12),

10. 8574861 - PPM1E proteins and nucleic acids as targets for neurodegenerative diseases (2013-11-05),

11. RE44555 - Method for analyzing chemical and/or biological samples by means of particle images (2013-10-21),

12. 8163901 - Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same (2012-04-24),

13. 8153651 - Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same (2012-04-10),

14. 8076345 - 2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof (2011-12-13),

15. 7867707 - Method for detecting analytes in a sample (2011-01-11),

Company Overview

Evotec AG is a global leader in drug discovery and development, headquartered in Hamburg, Germany. The company specializes in providing integrated solutions to pharmaceutical and biotechnology industries, focusing on innovative research and development services. Evotec's expertise spans various therapeutic areas, including neuroscience, oncology, and metabolic diseases, leveraging advanced technologies and collaborative partnerships to accelerate the drug development process. Their commitment to scientific excellence positions them as a key player in the biopharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

24 Patents

#45 in Hamburg

#1,912 in Germany

#26,701 in the World

Hamburg, Germany

Evotec Ag

Forward Citations = 22

52 inventors:

John Kincaid (5 out of 19 patents)

Donogh John Roger O'Mahony (4 out of 11 patents)

Zhi-Liang Wei (4 out of 10 patents)

4. Carl J Kaub (4 out of 11 patents)

5. Zhan Wang (3 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Evotec Ag. Retrieved from https://idiyas.com/company/evotec-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…